Aida Bairam Selected Research

Caffeine (No Doz)

10/2019	Erythropoietin and caffeine exert similar protective impact against neonatal intermittent hypoxia: Apnea of prematurity and sex dimorphism.
1/2017	Sex-specific respiratory effects of acute and chronic caffeine administration in newborn rats.
1/2017	Respiratory responses to progesterone and allopregnanolone following chronic caffeine treatment in newborn female rats.
1/2016	Inhibitory respiratory responses to progesterone and allopregnanolone in newborn rats chronically treated with caffeine.
11/2015	Prediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants.
1/2015	An Overview on the Respiratory Stimulant Effects of Caffeine and Progesterone on Response to Hypoxia and Apnea Frequency in Developing Rats.
3/2013	Effects of caffeine and/or nasal CPAP treatment on laryngeal chemoreflexes in preterm lambs.
1/2013	Role of ATP and adenosine on carotid body function during development.
10/2011	Impact of delivery room resuscitation on outcomes up to 18 months in very low birth weight infants.
8/2011	Alteration of carotid body chemoreflexes after neonatal intermittent hypoxia and caffeine treatment in rat pups.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aida Bairam Research Topics

Disease

30	Hypoxia (Hypoxemia) 01/2021 - 01/2003
19	Apnea 10/2019 - 04/2006
6	Sleep Apnea Syndromes (Sleep Apnea) 01/2021 - 01/2015
5	Hypercapnia 01/2021 - 04/2007
2	Hypertension (High Blood Pressure) 01/2019 - 01/2017
2	Birth Weight (Birth Weights) 11/2015 - 10/2011
1	Glucose Intolerance 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Wounds and Injuries (Trauma) 11/2017
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2016
1	Bradycardia 03/2013
1	Chronic Disease (Chronic Diseases) 01/2013
1	Hyperoxia 08/2012
1	Bronchopulmonary Dysplasia 10/2011
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2011
1	Cerebral Palsy (Spastic Diplegia) 10/2011
1	Hearing Loss (Hearing Impairment) 10/2011
1	Brain Injuries (Brain Injury) 10/2011
1	Premature Birth (Birth, Premature) 11/2009
1	Developmental Disabilities (Developmental Disability) 12/2008
1	Ganglion Cysts (Ganglion) 01/2003

Drug/Important Bio-Agent (IBA)

18	Caffeine (No Doz)FDA LinkGeneric 10/2019 - 04/2006
7	Estradiol (Delestrogen)FDA LinkGeneric 01/2021 - 01/2017
7	Progesterone FDA LinkGeneric 01/2020 - 02/2013
6	Respiratory System Agents (Respiratory Stimulants)IBA 10/2019 - 04/2006
5	Hormones (Hormone)IBA 01/2021 - 02/2009
4	Purinergic P1 Receptor AntagonistsIBA 01/2013 - 04/2006
3	Oxygen (Dioxygen)IBA 10/2019 - 08/2012
3	Messenger RNA (mRNA)IBA 11/2004 - 01/2003
3	Dopamine (Intropin)FDA LinkGeneric 01/2003 - 01/2003
2	Erythropoietin FDA Link 01/2021 - 10/2019
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 09/2016
2	SteroidsIBA 01/2019 - 01/2017
1	Insulin (Novolin)FDA Link 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	CytokinesIBA 11/2017
1	AntioxidantsIBA 01/2017
1	Pregnanolone (Allopregnanolone)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 09/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2015
1	U 0126 (UO 126)IBA 01/2015
1	Aminophylline (Carine)FDA LinkGeneric 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Theophylline (Theon)FDA LinkGeneric 01/2015
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2015
1	Protein Kinases (Protein Kinase)IBA 01/2015
1	XanthineIBA 01/2015
1	tetralinIBA 01/2013
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2013
1	Serotonin (5 Hydroxytryptamine)IBA 01/2013
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2013
1	Adenosine Triphosphate (ATP)IBA 01/2013
1	Purinergic P2 Receptors (ADP Receptor)IBA 01/2013
1	Carbon DioxideIBA 08/2012
1	Purinergic Receptors (Receptors, Purine)IBA 08/2012
1	Cholinergic Agents (Cholinergics)IBA 08/2012
1	Domperidone (Domperidon)IBA 08/2011
1	A-317491IBA 01/2011
1	Suramin (Suramin Sodium)IBA 01/2011
1	caffeine citrate FDA LinkGeneric 08/2010
1	Hexamethonium (Hexamethonium Bromide)IBA 12/2009
1	Nicotine FDA Link 12/2009
1	salicylhydroxamic acid (SHAM)IBA 02/2009
1	Testosterone (Sustanon)FDA Link 02/2009
1	TinIBA 12/2008
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 09/2008
1	ZM 241385 (ZM241385)IBA 04/2007
1	1,3-dipropyl-8-cyclopentylxanthineIBA 04/2007
1	Adenosine (Adenocard)FDA LinkGeneric 04/2007
1	Protein Isoforms (Isoforms)IBA 11/2004
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 11/2004
1	CatecholaminesIBA 01/2003
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2003

Therapy/Procedure

5	Therapeutics 01/2017 - 12/2008
2	Intraperitoneal Injections 01/2011 - 04/2007
1	Glycemic Control 01/2021
1	Aftercare (After-Treatment) 09/2016
1	Continuous Positive Airway Pressure 03/2013
1	Resuscitation 10/2011